*ST生物: 南华生物独立董事关于董事会换届选举的独立意见

Group 1 - The independent directors of Nanhua Biomedical Co., Ltd. have reviewed the board of directors' re-election process and found it to be compliant with relevant laws and regulations [1][2] - The nomination committee conducted thorough examinations of the professional backgrounds, work experiences, and qualifications of both non-independent and independent director candidates [1] - All candidates were confirmed to meet the qualifications required by the Company Law and were not subject to any disqualifications by the China Securities Regulatory Commission or the stock exchange [2] Group 2 - Independent director candidates possess the necessary professional knowledge, work experience, and decision-making abilities, meeting the independence requirements outlined in the Independent Director Management Measures [2] - The independent directors unanimously agreed to submit the relevant matters for shareholder meeting review, ensuring no harm to the interests of the company and all shareholders, particularly minority shareholders [2]